Patents by Inventor Qingxiang Yan

Qingxiang Yan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE LARGE B-CELL LYMPHOMA
    Publication number: 20240336697
    Abstract: Provided herein are methods of treating B-cell proliferative disorders (such as diffuse large B-cell lymphoma “DLBCL”) using immunoconjugates comprising anti-CD79b antibodies in combination with an anti-CD20 antibody, chemotherapy and a corticosteroid.
    Type: Application
    Filed: August 2, 2022
    Publication date: October 10, 2024
    Applicants: Genentech, Inc., Hoffmann-La Roche Inc.
    Inventors: Jamie Harue HIRATA, Calvin Ka Yin LEE, Huan JIN, Lijia WANG, Jiaheng QIU, Qingxiang YAN
  • BENZOTHIAZOLE MEROTERPENOID COMPOUND AND DERIVATIVE THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20230373938
    Abstract: A benzothiazole meroterpenoid compound derived from deep sea fungi and a derivative thereof, and a preparation method therefor and the use thereof in the preparation of an anti-tumor drug are provided. The benzothiazole meroterpenoid compound is a compound as represented by formulas I to III or a salt thereof. The compound is isolated from a fermentation product of deep-sea-derived Penicillium allii-sativi and inhibits the transcriptional activity of an anti-tumor target RXRalpha by means of binding thereto so as to achieve a remarkable anti-tumor effect. The compound can be used for preparing, researching and developing anti-cancer drugs, and has good application prospects.
    Type: Application
    Filed: March 18, 2021
    Publication date: November 23, 2023
    Applicant: THIRD INSTITUTE OF OCEANOGRAPHY, MINISTRY OF NATURAL RESOURCES
    Inventors: Xianwen YANG, Chunlan XIE, Qingxiang YAN, Zhenbiao ZOU, Zhihui HE
  • METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE LARGE B-CELL LYMPHOMA
    Publication number: 20230099756
    Abstract: Provided herein are methods of treating B-cell proliferative disorders (such as diffuse large B-cell lymphoma “DLBCL”) using immunoconjugates comprising anti-CD79b antibodies in combination with an anti-CD20 antibody, chemotherapy and a corticosteroid.
    Type: Application
    Filed: August 5, 2022
    Publication date: March 30, 2023
    Applicants: Genentech, Inc., Hoffmann-La Roche Inc.
    Inventors: Jamie Harue HIRATA, Calvin Ka Yin Lee, Huan Jin, Lijia Wang, Jiaheng Qiu, Qingxiang Yan